EM2010H "Updates on the Treatment of COVID-19"
The purpose of this presentation will be to review the latest scientific literature and guidelines regarding the pharmacologic treatments for coronavirus disease 2019 (COVID-19). The presentation will provide a brief overview of the stages and classification of COVID-19, followed by a evidence-based medicine review of the available literature on the proven or proposed treatments for this disease with commentary on how to apply this data to clinical practice. Finally, a series of overarching lessons for the scientific community will be highlighted based on this review of drug discovery for COVID-19.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- List the different phases of COVID-19 and which classes of treatment are likely to be most beneficial in each stage.
- Explain at least two reasons why randomized controlled trials are necessary to determine the efficacy of a new COVID-19 treatment.
- Describe a “sensible medicine” approach to the evaluation and clinical use of proposed new COVID-19 treatments.
James"Brad" Cutrell, M.D.
Associate Professor, Department of Internal Medicine
Program Director, Infectious Diseases Fellowship Program
Director, Antimicrobial Stewardship, Clements University Hospital and UTSW Systems
Division of Infectious Diseases and Geographic Medicine
- 1.00 AMA